Favourable reimbursement policies and high healthcare expenditure is expected to drive the United States blood glucose monitoring devices market for the forecast period.
According to TechSci Research report, “United States Blood Glucose Monitoring Devices Market By Product Type (Self Blood Glucose Monitoring Devices v/s Continuous Glucose Monitoring Devices) By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes) By End User (Home Care Settings, Hospital, Others) By Company, By Region, Forecast & Opportunities, 2026”, The United States blood glucose monitoring devices market is expected to witness significant growth for the next five years. Diabetes is a clinical condition in which the patient has higher level of glucose in the body due to inability of pancreas to produce insulin. Blood glucose monitoring devices are necessary for proper diagnosis and treatment as these devices measure the glucose level in the body. Excess of sugar in human body is called hyperglycemia and it can cause damage the vessels which supply the blood to various part of body can increase the risk of stroke and heart disease, vision and nerve problems and kidney diseases. Hypoglycemia is a condition in which the glucose level is lower than the normal level and it cause problems within central nervous systems. Blood glucose monitoring devices can help preventing these conditions and aids in taking necessary steps for maintaining the health condition of patients. Patients can measure the glucose levels in the comfort of their homes with the help of self blood glucose monitoring devices and check the effects of the treatment of diabetes and plan accordingly the diet, exercise stress management without facing any hassle. Also, the increasing United States government initiatives to increase the awareness among consumers the benefits of diabetes preventive care are boosting the blood glucose monitoring devices market growth.
The COVID-19 outbreak across the world which has been declared as pandemic by World Health Organization has affected countries adversely. Leading authorities in United States imposed lockdown restrictions and released a set of precautionary measures to contain the spread of novel coronavirus. Coronavirus affected patients started suffering from shortness of breath along with coughing and sneezing. United States authorities increased the capacity of hospitals as a greater number of patients were getting affected daily and getting admitted into the hospital facilities. Lockdown restrictions impacted the daily routine of diabetic patients such as eating patterns, physical conditions and patients indulged in adoption of sedentary lifestyle. These factors caused fluctuations in blood glucose level of patients which surged the demand for blood glucose monitoring devices.
Browse XX Figures spread through XX Pages and an in-depth TOC on “United States Blood Glucose Monitoring Devices Market”.
US blood glucose monitoring devices market is segmented into product type, application, end user, regional distribution, and company. Based on product type, market is further divided into self blood glucose monitoring devices and continuous glucose monitoring devices. The self blood glucose motoring devices segment is expected to dominate the market for the forecast period, 2022-2026. People measure their blood glucose levels with the help of self blood monitoring devices. This market is again fragmented into testing strips, lancets, and blood glucose meter. The testing strips segment is expected to maintain the significant share for the predicted period due to its cost-effectiveness and easy procedure for testing of blood glucose level in patient body.
Abbott Laboratories, Inc., Roche Diagnostics Corporation, Johnson & Johnson, Medtronic USA Inc., Becton, Dickinson, and Company, B. Braun Medical Inc., Nipro Medical Corporation, Dexcom, Inc., Sanofi-Aventis U.S. LLC, Eli Lilly and Company are the leading players operating in US blood glucose monitoring devices market. Manufacturers are increasingly focusing on research and development process to fuel higher growth in the market. To meet evolving customer demand with respect to better efficiency and durability, several blood glucose monitoring devices manufacturers are coming up with their technologically advanced offerings.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7489
Customers can also request for 10% free customization on this report.
“High prevalence of diabetes and changing lifestyle of people in United States is a major driver for the growth of the market. High-end investments by market players for technological advancements of blood glucose monitoring devices is contributing significantly to the market growth. Consumer preference towards wireless blood glucose monitoring devices which can be connected with smart phones using Wi-Fi protocols adds to the convenience and more user-friendly interface for consumers is expected to propel the growth of the market until 2026” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“United States Blood Glucose Monitoring Devices Market By Product Type (Self Blood Glucose Monitoring Devices v/s Continuous Glucose Monitoring Devices) By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes) By End User (Home Care Settings, Hospital, Others) By Company, By Region, Forecast & Opportunities, 2026” has evaluated the future growth potential of United States blood glucose monitoring devices market and provided statistics & information on market size, shares, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the of US blood glucose monitoring devices market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/